Grant: Engage Grants Program
University of Waterloo
$25,000.00
Predictive Model for a Novel, Low Cost, Single-Use Bioreactor
FY 2019-20
Summary
The objective of the current project is to generate and optimize a predictive 3-D model for a single-use bioreactor, particularly Membio's cartridge configuration single-use bioreactor. Upstream manufacturing technologies that are scalable, reliable, and cost-effective are now in high demand in pharmaceutical industry as single-use bioreactors to produce biologics. While Membio has expertise designing and constructing single-use bioreactors, no model yet exists to efficiently predict the effect of making design or operational changes to their bioreactors. Successful completion of this project will allow Membio to improve the design and operation of their biological manufacturing platform and direct their ongoing internal R&D of new product lines. The success of the project will also help strengthen Canadian bio-economy around biopharmaceutical manufacturing by improving a manufacturing platform that will be sold by Membio to enable cost-effective R&D, clinical trials, and commercialization of biologics. To date, various modeling approaches have been unsuccessful in their ability to predict the effect of changes to Membio's single-use bioreactor due to the novel nature of its design and operation. A robust, accurate, and integrative model, able to successfully predict the effect of design and operational alterations, is needed to drive new developments in biologics manufacturing. This proposal seeks to develop a predictive 3-D model for Membio's single-use bioreactor technology, the forerunner of upstream manufacturing technologies for the production of biologics, through the most cost-effective approaches available.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
538122-2019
Name nom
Simakov, David
Department département
Chemical Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Predictive Model for a Novel, Low Cost, Single-Use Bioreactor
Keyword
NSERC
Application summary
The objective of the current project is to generate and optimize a predictive 3-D model for a single-use bioreactor, particularly Membio's cartridge configuration single-use bioreactor. Upstream manufacturing technologies that are scalable, reliable, and cost-effective are now in high demand in pharmaceutical industry as single-use bioreactors to produce biologics. While Membio has expertise designing and constructing single-use bioreactors, no model yet exists to efficiently predict the effect of making design or operational changes to their bioreactors. Successful completion of this project will allow Membio to improve the design and operation of their biological manufacturing platform and direct their ongoing internal R&D of new product lines. The success of the project will also help strengthen Canadian bio-economy around biopharmaceutical manufacturing by improving a manufacturing platform that will be sold by Membio to enable cost-effective R&D, clinical trials, and commercialization of biologics. To date, various modeling approaches have been unsuccessful in their ability to predict the effect of changes to Membio's single-use bioreactor due to the novel nature of its design and operation. A robust, accurate, and integrative model, able to successfully predict the effect of design and operational alterations, is needed to drive new developments in biologics manufacturing. This proposal seeks to develop a predictive 3-D model for Membio's single-use bioreactor technology, the forerunner of upstream manufacturing technologies for the production of biologics, through the most cost-effective approaches available.